Facing patent expiration for its blockbuster Keytruda, Merck aims to streamline operations with significant job cuts and ...

The updated label no longer requires Leqvio (inclisiran) to be used in combination with statins for low-density lipoprotein ...

Regeneron has received a second complete response letter from the FDA for odronextamab and anticipates delays for Eylea HD ...